VIDEO: People with Parkinson’s freeze for ‘mannequin challenge’
Author: Almaz OhenePublished: 5 January 2017
Prep: Cook: Serves:
Parkinson’s campaigners worldwide are taking up the ‘mannequin challenge’ – the latest social media trend to sweep the web – to show that ‘freezing’ is part of everyday life for many people with the condition
To share the reality of ‘freezing of gait’, major Parkinson’s organisations around the world have filmed their own versions of the popular social media trend, the #MannequinChallenge. Here are three of the most popular – from Parkinson’s UK, the Parkinson Voice Project in the US and Parkinson’s NSW in Australia.
It launched a campaign featuring four videos showing people unable to move in everyday scenarios such as crossing the street, making a cup of tea and answering the front door.
The emotive messaging asks viewers to “Donate. Now. So their challenge can end.”
2. Parkinson Voice Project
Patients at the Parkinson Voice Project’s clinic in Texas, US, showed viewers the interactive and dynamic nature of their regular speech therapy classes, as they pause for a minute for the camera stunt.
3. Parkinson’s NSW
The Australian organisation took a different approach and focused on people with Parkinson’s tremors among those frozen in time.
4. Vlaamse Parkinson Liga
This challenge was an initiative by a group from Ghent, Belgium who are part of the Vlaamse Parkinson Liga (VPL), the Flemish Parkinson’s disease association. They wanted to highlight the fact that although Parkinson’s patients freeze due to stability problems, it’s also difficult to freeze on demand. The organisation’s president is Yves Meersman, who is also the lead chef behind the Parki’s Kookatelier project.
First it was ‘planking’, then came the ice bucket challenge, and now ‘mannequin challenge’ videos are sweeping the web – a viral internet video trend where people remain frozen in action like mannequins while a moving camera films them.
The third edition of the Ray Kennedy Cup is about to kick off in Denmark
4 days ago
Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?
A new study suggests that regular use of non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen may lower the risk of Parkinson’s associated with mutations of the LRRK2 gene – a common genetic cause of the condition. As part of the study, researchers analysed the data for 577 individuals with the LRRK2 gene mutation. They found that regular use of aspirin and ibuprofen – at least two pills per week for at least six months – was more prevalent in people who did not have Parkinson’s compared to those with the condition. Across the study, the use of NSAIDs corresponded with roughly a 66% decrease in the risk of Parkinson’s. The researchers say that “the results of this study suggest that the regular use of NSAID medication may lower the risk for Parkinson’s among LRRK2 variant carriers … for both ibuprofen and aspirin” but more research will need to be…
US hospital initiative improves on-time administration of Parkinson’s medication
Late or missed doses of Parkinson’s medication in hospitals can lead to longer stays and greater morbidity. To counteract this issue, a team of healthcare professionals in the US launched a project to improve the on-time administration of levodopa to people with Parkinson’s. As part of the initiative – published in the Journal of Parkinson’s Disease – several measures were implemented, including electronic alerts for nurses, stocking automated medication dispensing machines with carbidopa-levodopa products, reporting to nurse unit managers on timeliness of medication administration and more. Dr Martha A Nance, the project’s lead investigator, said: “This project was very rewarding for our team, because of its obvious, immediate, and important impact on patient care. “We have reason to think that timely administration of carbidopa-levodopa may be associated with shorter stays and better outcomes and satisfaction. Anecdotally, patients have reported being surprised and pleased that nurses were reminding them that medication…
Does deep brain stimulation for Parkinson’s increase the risk of dementia?
Researchers in France have found that deep brain stimulation for Parkinson’s may not increase the risk of developing dementia. As part of the study – published by the American Academy of Neurology – researchers identified 175 people with Parkinson’s and an average age of 56, who had deep brain stimulation. The individuals were assessed over a period of 10 years to determine if they had developed dementia. After one year, four individuals had developed dementia. After five years, 142 people from the original group were available for testing, 12 of whom had dementia. After 10 years, 104 people were available for testing, 31 of whom had dementia. Dr Elena Moro, author of the study, said: “These results are very encouraging for people with Parkinson’s and their families that they can take advantage of the benefits of deep brain stimulation without worrying about it increasing the likelihood of developing dementia.”